| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.19 | 0.6 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.19 | 0.5 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.009 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |